Table 1.
Demographic and clinical characteristics of transmen prescribed testosterone for gender affirming hormone treatment (GAHT) and cisgender men prescribed testosterone for testosterone deficiency (TD), N = 486.
| Characteristicsa | GAHT, n (%) | TD, n (%) | p value |
|---|---|---|---|
| Overall | 277 | 209 | – |
| Age group, (n = 485) | <0.001 b | ||
| <30 | 178 (64.3) | 7 (3.4) | |
| 30–39 | 60 (21.7) | 18 (8.7) | |
| 40–49 | 20 (7.2) | 36 (17.3) | |
| 50+ years | 19 (6.9) | 147 (70.1) | |
| Age (years), mean (SD) | 29.8 (9.9) | 54.9 (12.1) | <0.001c |
| BMI group, (n = 436) | <0.001 b | ||
| <25 | 118 (48.6) | 42 (21.8) | |
| 25–30 | 66 (27.2) | 86 (44.6) | |
| >30 | 59 (24.3) | 65 (33.7) | |
| HIV status (n = 480) | <0.001 b | ||
| HIV positive | 0 (0.0) | 99 (47.6) | |
| HIV negative | 116 (42.7) | 95 (45.7) | |
| No recorded test | 156 (56.3) | 14 (6.7) | |
| Smoking status, (n = 466) | <0.001 b | ||
| Current smoker | 57 (21.8) | 44 (21.8) | |
| Former smoker | 32 (12.2) | 66 (32.7) | |
| Never smoker | 173 (66.0) | 92 (45.5) | |
| Anxiety and/or depression, (n = 485) | 0.117b | ||
| Yes | 103 (37.2) | 92 (44.2) | |
| No | 174 (62.8) | 116 (55.8) |
a
The difference in the number of observations for each characteristic and the total number indicated in the heading comprises missing or unknown observations.
b
Chi-squared test of independence was used; cIndependent sample t-test was used.